404

Not Found

Is this what you were looking for?

20http www allergan com index htm
By Kelsey Kaustinen

A white knight for Allergan?

As Valeant's pursuit of Allergan continues, sources claim Actavis is in talks to acquire the company
By Kelsey Kaustinen

Valeant announces merger proposal for Allergan

Proposal calls for each share of Allergan stock to be exchanged for $48.30 in cash and 0.83 shares of Valeant stock; Allergan launches stockholder rights plan in response
By Kelsey Kaustinen

A busy June for Teva

Pharma giant inks several agreements divesting assets in preparation for closing Allergan generics deal
By Kelsey Kaustinen

Keeping an eye on DARPins

Molecular Partners, Allergan announce a pair of ophthalmology-focused agreements based on Molecular Partners' DARPin platform

Run a Search

March 2024 Issue Front Cover

Latest Issue  

• Volume 20 • Issue 2 • March 2024

March 2024

March 2024 Issue